Eosinophilic pneumonia after administration of fludarabine for the treatment of non-Hodgkin's lymphoma

被引：0
|
作者：
A. Trojan
R. Meier
A. Licht
C. Taverna
机构：
[1] Division of Oncology,
[2] Department of Internal Medicine,undefined
[3] University Hospital,undefined
[4] Rämistrasse 100,undefined
[5] 8091 Zürich,undefined
[6] Switzerland,undefined
[7] Department of Internal Medicine,undefined
[8] Stadtspital Triemli,undefined
[9] Birmensdorferstrasse 497,undefined
[10] 8063 Zürich,undefined
[11] Switzerland,undefined
来源：
Annals of Hematology | 2002年 / 81卷
关键词：
Fludarabine Pulmonary toxicity Acute eosinophilic pneumonia Follicular non-Hodgkin's lymphoma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Fludarabine is a purine analogue which is effective in the treatment of patients with low-grade non-Hodgkin's lymphoma, including chronic lymphocytic leukemia. While pulmonary toxicity due to cytotoxic drugs is increasingly diagnosed, only few cases of interstitial pneumonitis have been described following fludarabine administration. Here we report the first case in the literature of an acute eosinophilic pneumonia associated with peripheral blood eosinophilia after the administration of fludarabine monotherapy for stage IV follicular lymphoma.
引用
收藏
页码：535 / 537
页数：2
相关论文
共 50 条
  • [1] Eosinophilic pneumonia after administration of fludarabine for the treatment of non-Hodgkin's lymphoma
    Trojan, A
    Meier, R
    Licht, A
    Taverna, C
    ANNALS OF HEMATOLOGY, 2002, 81 (09) : 535 - 537
  • [2] Pharmacotherapy Update: Fludarabine in the Treatment of Non-Hodgkin's Lymphoma
    Shvidel, Lev
    Cohn, Mirel
    Sigler, Erica
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2009, 1 : 359 - 377
  • [3] Eosinophilic pneumonia revealing B-cell non-Hodgkin lymphoma
    Fikal, Siham
    Sajiai, Hafsa
    Serhane, Hind
    Aitbatahar, Salma
    Amro, Lamyae
    PAN AFRICAN MEDICAL JOURNAL, 2016, 24
  • [4] Fludarabine - A review of its use in non-hodgkin's lymphoma
    Anderson, Vanessa R.
    Perry, Caroline M.
    DRUGS, 2007, 67 (11) : 1633 - 1655
  • [5] Clinical experience with fludarabine in indolent non-Hodgkin's lymphoma
    Zinzani, PL
    HEMATOLOGY JOURNAL, 2004, 5 : S38 - S49
  • [6] Treatment of non-Hodgkin's lymphoma
    Dranitsaris, G
    ANTI-CANCER DRUGS, 1998, 9 (10) : 879 - 888
  • [7] Essential thrombocythemia after treatment of non-Hodgkin's lymphoma
    Maciel, J. F. R.
    de Lourdes Chauffaille, M.
    Inaoka, R. J.
    Colleoni, G. W. B.
    Yamamoto, M.
    LEUKEMIA RESEARCH, 2007, 31 (11) : 1593 - 1595
  • [8] Seropositive symmetrical inflammatory polyarthritis appearing after treatment with fludarabine in a patient with non-Hodgkin's lymphoma.
    Kouroukis, C
    Boulos, P
    Haines, P
    Adachi, JD
    Meyer, RM
    BLOOD, 2000, 96 (11) : 241B - 241B
  • [9] The treatment of Hodgkin's and non-Hodgkin's lymphoma in pregnancy
    Pereg, David
    Koren, Gideon
    Lishner, Michael
    HAEMATOLOGICA, 2007, 92 (09) : 1230 - 1237
  • [10] Fludarabine in alkylator-resistant follicular non-Hodgkin's lymphoma
    Tinmouth, A
    Zanke, B
    Imrie, KR
    LEUKEMIA & LYMPHOMA, 2001, 41 (1-2) : 137 - 145
12345